semaglutide patent india Novo Nordisk expiry opens door to cheaper weight-loss drugs in India could soon get a

[ 4 ] Instead, several hypotheses have been proposed based on preclinical investigations

The most common explanations relate to the metabolic and behavioral changes that accompany effective weight loss treatment

It could potentially also cause serotonin syndrome, a serious condition resulting from high serotonin levels

Reviews are generally fairly negative, with many customers complaining about unclear pricing

The company, for now, allows consumers to get compounded semaglutide, which pharmacies are allowed to dispense over the next month, according to the FDA

Important: The timeline below is educational and should not be interpreted as a prediction of your individual results